A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

(2012) D. FARGE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review

(2011) Melanie Tan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Guidelines on oral anticoagulation with warfarin - fourth edition

(2011) David Keeling et al.   BRITISH JOURNAL OF HAEMATOLOGY

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study

(2010) B. Cosmi et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients

(2010) Sharon M. Watanabe et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action

(2009) Alok A. Khorana et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis

(2008) Simon IR Noble et al.   LANCET ONCOLOGY